Show items per page
Elements: 66
Page 1 on 4
 TitleAuthors / EditorsDate
add to browser selection
Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection Yerly Ferrillo, Sabine; Perneger, T. V.; Vora, S.; Hirschel, Bernard; Perrin, Luc 2000
add to browser selection
HIV transmission after suspension of highly active antiretroviral therapy Bernasconi, Enos; Vernazza, P. L.; Bernasconi, Alessandra; Hirschel, Bernard 2001
add to browser selection
Impact of occasional short interruptions of HAART on the progression of HIV infection: results from a cohort study Taffe, Patrick; Rickenbach, Martin; Hirschel, Bernard; Opravil, Milos; ... Sudre, Philippe 2002
add to browser selection
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study Mocroft, A.; Phillips, A. N.; Friis-Moller, N.; Colebunders, R.; ... Lundgren, J. D. 2002
add to browser selection
Clinical efficacy of early initiation of HAART in patients with asymptomatic HIV infection and CD4 cell count > 350 x 10(6) Opravil, Milos; Ledergerber, Bruno; Furrer, Hansjakob; Hirschel, Bernard; ... Weber, Rainer 2002
add to browser selection
Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection Oxenius, Annette; Price, D. A.; Gunthard, Huldrych; Dawson, S. J.; ... Phillips, R. E. 2002
add to browser selection
Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy Greub, Gilbert; Cozzi-Lepri, Alessandro; Ledergerber, Bruno; Staszewski, Schlomo; ... Telenti, Amalio 2002
add to browser selection
A patient with HIV-1 superinfection Jost, Stéphanie; Bernard, Marie-Charlotte; Kaiser, Laurent; Yerly Ferrillo, Sabine; ... Perrin, Luc 2002
add to browser selection
Weight-losing HIV-infected patients on recombinant human growth hormone for 12 wk: a national study Cominelli, Silvano; Raguso, C. A.; Karsegard, Laurie; Hirschel, Bernard; ... Pichard, Claude 2002
add to browser selection
Supervised interruptions of antiretroviral therapy Deeks, S. G.; Hirschel, Bernard 2002
add to browser selection
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study Kaufmann, G. R.; Perrin, Luc; Pantaleo, Guiseppe; Opravil, Milos; ... Battegay, Manuel 2003
add to browser selection
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population Jaggy, Christian; von Overbeck, Jan; Ledergerber, Bruno; Schwarz, Claude; ... Hirschel, Bernard 2003
add to browser selection
Drug resistance mutations during structured treatment interruptions Yerly Ferrillo, Sabine; Fagard, Catherine; Gunthard, Huldrych; Hirschel, Bernard; Perrin, Luc 2003
add to browser selection
A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART Fagard, Catherine; Le Braz, Michelle; Gunthard, Huldrych; Hirsch, H. H.; ... Hirschel, Bernard 2003
add to browser selection
A prospective trial of structured treatment interruptions in human immunodeficiency virus infection Fagard, Catherine; Oxenius, Annette; Gunthard, Huldrych; Garcia, Felipe; ... Hirschel, Bernard 2003
add to browser selection
Is autovaccination dead? Hirschel, Bernard 2003
add to browser selection
Structured treatment interruptions in HIV infection: benefit or disappointment? Oxenius, Annette; Hirschel, Bernard 2003
add to browser selection
Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection Kaufmann, G. R.; Khanna, Nina; Weber, Rainer; Perrin, Luc; ... Battegay, Manuel 2004
add to browser selection
Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions Yerly Ferrillo, Sabine; Gunthard, Huldrych; Fagard, Catherine; Joos, Beda; ... Perrin, Luc 2004
add to browser selection
Pharmacokinetic study of saquinavir hard gel caps/ritonavir in HIV-1-infected patients: 1600/100 mg once-daily compared with 2000/100 mg once-daily and 1000/100 mg twice-daily Autar, R. S.; Ananworanich, J.; Apateerapong, W.; Sankote, J.; ... Burger, Danielle 2004
<< previous | 1 | 2 | 3 | 4 |